Causes of Elevated Bilirubin
Unconjugated (indirect) hyperbilirubinemia is caused by hemolysis or impaired conjugation (most commonly Gilbert's syndrome), while conjugated (direct) hyperbilirubinemia results from parenchymal liver disease or biliary obstruction 1.
Unconjugated (Indirect) Hyperbilirubinemia
The primary mechanisms are:
Increased Bilirubin Production
- Hemolytic disorders causing accelerated red blood cell destruction 1, 2
- Any condition that increases erythrocyte breakdown will overwhelm the liver's conjugation capacity
Impaired Hepatic Conjugation
- Gilbert's syndrome - the most common cause of isolated elevated bilirubin, due to reduced glucuronyltransferase enzyme activity 1
- In the absence of hemolysis, if the majority of elevated bilirubin is unconjugated, the cause is virtually always Gilbert's syndrome 1
- These patients should be fully reassured as this is benign 1
- Bilirubin typically ranges 1.2-3.0 mg/dL, occasionally up to 5.0 mg/dL, though rare cases reach 10.3 mg/dL 3
- Crigler-Najjar syndrome (Type I and Type II) - inherited disorders of bilirubin conjugation 4
- Drug-induced inhibition of UGT1A1 (the conjugating enzyme) 5, 6
Important Clinical Caveat
In neonates, physiological unconjugated hyperbilirubinemia is common but may be pathological if high or prolonged 1. If conjugated bilirubin exceeds 25 μmol/L in neonates and infants, urgent referral to a pediatrician is essential 1.
Conjugated (Direct) Hyperbilirubinemia
The key mechanisms are:
Hepatocellular Damage
- Viral hepatitis 2
- Alcoholic hepatitis 2
- Drug-induced liver injury - particularly with nucleoside and non-nucleoside HIV reverse transcriptase inhibitors 5
- Autoimmune hepatitis
- Any parenchymal liver disease causing hepatocellular injury 1
Cholestatic Disorders
- Biliary obstruction - choledocholithiasis, neoplastic obstruction of the biliary tree 2
- Primary sclerosing cholangitis 7
- Genetic cholestatic diseases - mutations affecting bile formation/flow 7
Drug-Induced Mechanisms
- Inhibition of OATP1B1/1B3 transporters - impairs hepatic uptake and re-uptake of conjugated bilirubin 4, 6
- Inhibition of MRP2 - blocks canalicular excretion of conjugated bilirubin 8, 6
- Inhibition of BSEP - impairs bile flow 6
Mixed Hyperbilirubinemia
Some conditions cause elevation of both fractions:
- Advanced liver disease with both impaired conjugation and excretion 5
- Hepatic encephalopathy - associated with markedly elevated direct bilirubin 9
- Sepsis and systemic inflammatory disorders - can affect multiple pathways 1
Diagnostic Approach
The guideline-recommended algorithm is straightforward 1, 2:
- Fractionate the bilirubin to determine which component is elevated
- If predominantly unconjugated: Rule out hemolysis (complete blood count, reticulocyte count, haptoglobin, LDH)
- If no hemolysis → Gilbert's syndrome (reassure patient)
- If predominantly conjugated: Check ALT, AST, alkaline phosphatase, γ-glutamyltransferase
- Elevated transaminases → hepatocellular disease
- Elevated alkaline phosphatase/GGT → cholestatic disease
- Proceed to imaging (ultrasonography first) to differentiate intrahepatic vs. extrahepatic obstruction 2
For genetic cholestatic diseases, early genetic testing using next-generation sequencing panels or whole-exome sequencing is recommended, particularly in infants/children or adults with unusual features unresponsive to initial treatment 7.